Mutations or inactivation of the PTEN gene can lead to phosphatase inactivation, thereby losing the ability to inhibit cell proliferation, causing cells to become malignant and inducing the occurrence of endometrial cancer, while also potentially decreasing the sensitivity of cancer cells to chemotherapy drugs [23]. The gene discussed is PTEN; the disease is endometrial cancer.